فاس نيوز ميديا جريدة الكترونية جهوية تعنى بشؤون و أخبار جهة فاس مكناس – متجددة على مدار الساعة
The British pharmaceutical company AstraZeneca announced the withdrawal of its Covid-19 vaccine from the market, one of the first vaccines produced during the pandemic, for what it called “commercial reasons” and “a surplus of updated vaccines.”
The AstraZeneca group confirmed in a press release, “With the development of multiple vaccines for Covid-19, there is a surplus of updated vaccines for different types of the virus, which has led to a decrease in demand. AstraZeneca has therefore taken the decision to begin withdrawing the marketing authorization for Vaxzevria in Europe.”
This step comes after AstraZeneca admitted last April, for the first time, that its vaccine against the Corona virus could cause fatal side effects associated with blood clotting.
According to the British newspaper Daily Mail, AstraZeneca is facing a multi-million pound class action lawsuit from dozens of families who claim they were harmed or lost loved ones because of its “defective” vaccine.
From: Fez News website
